Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Growth in precocious puberty.

Justin J Brown1, Garry L Warne

  • 1Department of Endocrinology and Diabetes Royal Children's Hospital, Parkville, Victoria, Australia.

Indian Journal of Pediatrics
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case of vertebral fracture with nephrolithiasis and hypocitraturia.

Journal of paediatrics and child health·2021
Same author

Management of disorders of sex development - With a focus on development of the child and adolescent through the pubertal years.

Best practice & research. Clinical endocrinology & metabolism·2019
Same author

Another Look at Hereditary Partial Androgen Insensitivity Syndrome in an Indigenous Community in the Northern Territory of Australia.

Journal of paediatrics and child health·2017
Same author

Fertility in Turner syndrome.

Clinical endocrinology·2013
Same author

Advice on the management of ambiguous genitalia to a young endocrinologist from experienced clinicians.

Seminars in reproductive medicine·2012
Same author

Hormone treatment of gender identity disorder in a cohort of children and adolescents.

The Medical journal of Australia·2012
Same journal

Beyond Proteinuria: Does Growth Matter in Childhood Nephrotic Syndrome?

Indian journal of pediatrics·2026
Same journal

Impulse Oscillometry for Pulmonary Function Evaluation in Children with Neuromuscular Disease: A Comparative Study with Spirometry - Correspondence.

Indian journal of pediatrics·2026
Same journal

Impact of Enzyme Replacement Therapy on Patients with Late Onset Pompe Disease - Real World Data from a Developing Country.

Indian journal of pediatrics·2026
Same journal

Reciprocal Interaction Loss During Screen-Assisted Feeding: The Dominant Language Risk Component in Early Childhood.

Indian journal of pediatrics·2026
Same journal

Bilateral Parotid Enlargement as an Initial Manifestation of Pediatric Acute Lymphoblastic Leukemia.

Indian journal of pediatrics·2026
Same journal

Hemorrhagic Cardiac Tamponade Due to MRSA Sepsis in a Child with Relapsed Acute Lymphoblastic Leukemia: Authors' Reply.

Indian journal of pediatrics·2026
See all related articles

Precocious puberty growth concerns are addressed. Gonadotropin-releasing hormone agonists may improve final height in girls with rapidly progressing central precocious puberty if treated before age eight.

Area of Science:

  • Pediatric Endocrinology
  • Growth and Development
  • Puberty Disorders

Background:

  • Precocious puberty is a growing concern for families and clinicians.
  • Debate exists regarding its definition and the influence of obesity on onset age.
  • Understanding growth patterns and progression rates is crucial for assessing height outcomes.

Purpose of the Study:

  • To review current understanding of growth patterns in precocious puberty.
  • To evaluate the effectiveness of interventions on final height.
  • To discuss factors influencing treatment decisions.

Main Methods:

  • Review of existing literature and clinical data.
  • Analysis of growth patterns in normal and precocious puberty.
  • Assessment of treatment effects, particularly GnRH agonists.

Related Experiment Videos

Main Results:

  • Height outcomes are generally not compromised in untreated, slowly progressive central precocious puberty.
  • Gonadotropin-releasing hormone agonists increased final height by ~5 cm in girls treated before age eight for rapidly progressing central precocious puberty.
  • No significant height benefit observed in girls treated after age eight; limited data for boys.

Conclusions:

  • Treatment decisions for central precocious puberty require consideration of progression rate, biochemical markers, and psychosocial factors.
  • GnRH agonists appear safe and effective for specific patient groups.
  • Further research is needed, especially for treatment effects in boys.